MK615, a prospective anti-proliferative agent, enhances CD4/CD8 ratio after exposure to irradiation

References

• Adachi M, Suzuki Y, Mizuta T, Osawa T, Adachi T, Osaka K, Suzuki K, Shiojima K, Arai Y, Masuda K, Uchiyama M, Oyamada T, Clerici M. 2007. The ‘Prunus mume Sieb. et Zucc’ (ume) is a rich natural source of noval anti-cancer substance. International Journal of Food Properities 10:375–384.
   Google Scholar
• Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K, Tamura T. 1996. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry 43:1255–1260.
   PubMed Web of Science ®Google Scholar
• Altmann H, Tuschl H. 1978. DNA-repair in lymphocytes of persons living in elevated natural background radiation areas (Badgastein). Late biological effects of ionizing radiation. WienIAEA
   Google Scholar
• Brinkhaus B, Lindner M, Schuppan D, Hahn EG. 2000. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 7:427–448.
   PubMed Web of Science ®Google Scholar
• Briot E, Dutreix A, Bridier A. 1990. Dosimetry for total body irradiation. Radiotherapy & Oncology 18(Suppl. 1):16–29.
   PubMedGoogle Scholar
• Cohen PA, Peng L, Kjaergaard J, Plautz GE, Finke JH, Koski GK, Czerniecki BJ, Shu S. 2001. T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance. Critical Reviews in Immunology 21:215–248.
   PubMed Web of Science ®Google Scholar
• Corthay A, Skovseth DK, Lundin KU, Rosjo E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B. 2005. Primary antitumour immune response mediated by CD4+ T cells. Immunity 22:371–383.
   PubMed Web of Science ®Google Scholar
• Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. 2002. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Research 62:1462–1470.
   PubMed Web of Science ®Google Scholar
• Hasler A, Sticher O, Meier B. 1990. High-performance liquid chromatographic determination of five widespread flavonoid aglycones. Journal of Chromatography A 508:236–240.
   PubMed Web of Science ®Google Scholar
• Hersey P, Menzies SW, Halliday GM, Nguyen T, Farrelly ML, DeSilva C, Lett M. 2004. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunology Immunotherapy 53:125–134.
   PubMed Web of Science ®Google Scholar
• Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. 1998. The central role of CD4(+) T cells in the antitumor immune response. Journal of Experimental Medicine 188:2357–2368.
   PubMed Web of Science ®Google Scholar
• Husmann LA, Bevan MJ. 1988. Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Annals of the NewYork Academy of Sciences 532:158–169.
   PubMed Web of Science ®Google Scholar
• Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK. 2009. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. International Immunopharmacology 9:113–119.
   PubMed Web of Science ®Google Scholar
• Jiang RW, Lane AL, Mylacraine L, Hardcastle KI, Fairchild CR, Aalbersberg W, Hay ME, Kubanek J. 2008. Structures and absolute configurations of sulfate-conjugated triterpenoids including an antifungal chemical defense of the green macroalga Tydemania expeditionis. Journal of Natural Products 71:1616–1619.
   PubMedGoogle Scholar
• Job G, Pfreundschuh M, Bauer M, zum WK, Hunstein W. 1984. The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodies. International Journal of Radiation Oncololog Biology Physics 10:2077–2081.
   PubMedGoogle Scholar
• Johnke RM, Edwards JM, Kovacs CJ, Evans MJ, Daly BM, Karlsson UL, Lee TK, Allison RR, Arastu HH, Cariveau MJ, O'Brien KF. 2005. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: Influence of neoajuvant total androgen suppression. Anticancer Research 25:3159–3166.
   PubMedGoogle Scholar
• Keene JA, Forman J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. Journal of Experimental Medicine 15:768–782.
   Google Scholar
• Kimoto T, Arai S, Kohguchi M, Aga M, Nomura Y, Micallef MJ, Kurimoto M, Mito K. 1998. Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detection and Prevention 22:506–515.
   PubMedGoogle Scholar
• Leer JW, Broerse JJ, De VH, Chin A, Noordijk EM, Dutreix A. 1990. Techniques applied for total body irradiation. Radiotherapy & Oncology 18(Suppl. 1):10–15.
   PubMedGoogle Scholar
• Lissoni P, Meregalli S, Bonetto E, Mancuso M, Brivio F, Colciago M, Gardani G. 2005. Radiotherapy-induced lymphocytopenia: Changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. Journal of Biological Regulators and Homeosttic Agents 19:153–158.
   PubMed Web of Science ®Google Scholar
• Manez S, Recio MC, Giner RM, Rios JL. 1997. Effect of selected triterpenoids on chronic dermal inflammation. Europian Journal of Pharmacology 334:103–105.
   PubMed Web of Science ®Google Scholar
• Marciani DJ, Press JB, Reynolds RC, Pathak AK, Pathak V, Gundy LE, Farmer JT, Koratich MS, May RD. 2000. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine 18:3141–3151.
   PubMedGoogle Scholar
• Mitchell MS, Darrah D, Yeung D, Halpern S, Wallace A, Voland J, Jones V, Kan-Mitchell J. 2002. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. Journal of Clinical Oncology 20:1075–1086.
   PubMed Web of Science ®Google Scholar
• Mori S, Sawada T, Okada T, Ohsawa T, Adachi M, Keiichi K. 2007. New anti-proliferative agent, MK615, from Japanese apricot ‘Prunus mume’ induces striking autophagy in colon cancer cells in vitro. World Journal of Gastroenterology 13:6512–6517.
   PubMedGoogle Scholar
• Morimoto Y, Kikuchi K, Ito T, Tokuda M, Matsuyama T, Noma S, Hashiguchi T, Torii M, Maruyama I, Kawahara K. 2009. MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced pro-inflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. Biochemical and Biophysical Research Communications 389:90–94.
   PubMedGoogle Scholar
• Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, Schreiber RD, Schreiber H. 1999. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proceedings of the National Academy of Sciences of the USA 96:8633–8638.
   PubMed Web of Science ®Google Scholar
• Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi M, Kubota K. 2007. New antineoplastic agent, MK615, from UME (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Breast Journal 13:44–49.
   PubMed Web of Science ®Google Scholar
• Nocerino E, Amato M, Izzo AA. 2000b. Cannabis and cannabinoid receptors. Fitoterapia (Suppl. 1):S6–12.
   Google Scholar
• Nocerino E, Amato M, Izzo AA. 2000a. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 71(Suppl. 1):S1–5.
   PubMedGoogle Scholar
• Okada T, Sawada T, Osawa T. 2007. A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity. Hepatogastroenterology 54:1770–1774.
   PubMedGoogle Scholar
• Okada T, Sawada T, Osawa T, Adachi M, Kubota K. 2008. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World Journal of Gastroenterology 14:1378–1382.
   PubMedGoogle Scholar
• Pardoll DM, Topalian SL. 1998. The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology 10:588–594.
   PubMed Web of Science ®Google Scholar
• Park HR, Jung U, Jo SK. 2007. Impairment of natural killer (NK) cells is an important factor in a weak Th1-like response in irradiated mice. Radiation Research 168:446–452.
   PubMed Web of Science ®Google Scholar
• Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P. 2007. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109:5346–5354.
   PubMed Web of Science ®Google Scholar
• Powell DJ Jr, Dudley ME, Hogan KA, Wunderlich JR, Rosenberg SA. 2006. Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion. Journal of Immunology 177:6527–6539.
   PubMed Web of Science ®Google Scholar
• Qin Z, Blankenstein T. 2000. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12:677–686.
   PubMed Web of Science ®Google Scholar
• Rao AV, Gurfinkel DM. 2000. The bioactivity of saponins: Triterpenoid and steroidal glycosides. Drug Metabolism and Drug Interactions 17:211–235.
   PubMedGoogle Scholar
• Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P, Bender A, Feuerstein B, Fritsch PO, Romani N, Schuler G. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. Journal of Experimental Medicine 195:1279–1288.
   PubMed Web of Science ®Google Scholar
• Shank B. 1983. Techniques of magna-field irradiation. International Journal of Radiation Oncololog Biology Physics 9:1925–1931.
   PubMed Web of Science ®Google Scholar
• Speiser DE, Pittet MJ, Rimoldi D, Guillaume P, Luescher IF, Lienard D, Lejeune F, Cerottini JC, Romero P. 2003. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells. Seminars in Cancer Biology 13:461–472.
   PubMed Web of Science ®Google Scholar
• Takasaki M, Konoshima T, Murata Y, Sugiura M, Nishino H, Tokuda H, Matsumoto K, Kasai R, Yamasaki K. 2003. Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Letter 198:37–42.
   PubMed Web of Science ®Google Scholar
• Wang RF. 2006. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer. Seminars in Cancer Biology 16:73–79.
   PubMed Web of Science ®Google Scholar
• Wasik M, Gorska E, Modzelewska M, Nowicki K, Jakubczak B, Demkow U. 2007. The influence of low-power helium-neon laser irradiation on function of selected peripheral blood cells [abstract]. In: The influence of low-power helium-neon laser irradiation on function of selected peripheral blood cells. Journal of Physiology and Pharmacology 58(Suppl. 5)Pt 2: 729–737.
   PubMedGoogle Scholar
• Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y, Tangoku A. 2009. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. International Journal of Cancer 125:952–960.
   PubMedGoogle Scholar
• Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. 2002. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells. Proceedings of the National Academy of Sciences of the USA 99:16168–16173.
   PubMed Web of Science ®Google Scholar